Rigel Pharmaceuticals SG&A Expense (TTM) Insights

Rigel Pharmaceuticals, Inc. (RIGL)

44.57 +0.63 (+1.43%) USD | NASDAQ | Dec 24, 12:59

44.64 +0.06 (+0.15%) After-Hours: 13:59

View SG&A Expense (TTM) for RIGL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (TTM) Chart

Start Trial

View Historical Data

Start Trial

View SG&A Expense (TTM) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View SG&A Expense (TTM) Benchmarks

Start Trial

Eli Lilly & Co.	10.39B
Catalyst Pharmaceuticals, Inc.	162.44M
Amicus Therapeutics, Inc.	353.07M
Perspective Therapeutics, Inc.	31.53M
Nektar Therapeutics	74.62M